Emerging markets (EM) have historically reacted with deep declines to high inflation and interest rate hikes. Although EM equities are in one of the longest-running bear markets, there is a sustainable turning point for the asset class, according to Barings.
The investment management firm says that the withdrawal of stimulus hit corporate earnings, while the outflows from China markets hit EM equities. Other factors include the war in Ukraine and the rally of the US dollar.
“Given the challenges outlined above, it is easy to understand why EM equities remain out of favor. However, as longterm investors, it is also important to recognize that these headwinds are now well-known and already reflected in earnings expectations and valuations of EM equities,” write Michael Levy and William Palmer, Co-heads for Emerging Equities at Barings.
Barings believes some of the headwinds facing EM equities have now begun to fade, with policy changes in China and interest rates likely peaking in Brazil. Barings says that in China, which has a large weightage among EM indexes, regulatory review and implementation seem to be largely complete and the audit issue with the US is being resolved.
“In the near term, global inflationary pressures and monetary tightening concerns are likely to keep volatility elevated across equity markets, until investors have an inflection point in sight, which could potentially coincide with a peak in U.S. dollar strength,” says Barings.
Read more

Global Trade
Trump ignites global trade war / Reactions
The USA itself will be the victim of Trump’s trade policy.

Private Debt
The case for private debt in real asset financing
What makes the combination of private debt and real assets particularly compelling in today’s market?

Schroders
Looking ahead: 30-year return forecasts
Higher returns are expected across asset classes, driven by stronger productivity growth for equities and elevated long-term central bank rate projections for bonds.

Quant Investing
AI and quantitative investing
Artificial intelligence applications go way beyond stock selection.

Bellevue Asset Management
Demographics and AI drive MedTech stocks
MedTech investment case: What makes it attractive, which trends stand out?